← Leaderboards
Michael Rosenzweig
Harvard University (Medical School)
$2,256,517
Attributed
$2,755,518
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,755,518 · 11
By mechanism
R44$998,002 · 1
P51$887,775 · 4
R43$481,532 · 2
R21$260,100 · 1
R29$117,998 · 1
M01$10,111 · 2
Top collaborators
- Randolph J. Noelle1 shared
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Andrew A Lackner$56,391,965
- R. Paul Johnson$56,310,063
- Zheng W Chen$26,721,709
- Keith G. Mansfield$12,495,552
- Ronald C Desrosiers$52,941,615
Others in their field
Top investigators on “Cellular Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$362,792,246
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$302,377,251
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$232,589,547
- Barton F Haynes · Duke University$105,397,476
- Dan H. Barouch · Fred Hutchinson Cancer Center$98,474,803
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$81,038,836
Research focus
Cellular ImmunityT LymphocyteMacaca MulattaHematopoietic Stem CellsTissue /Cell CultureAntigen-Presenting CellsAntibody AffinityAnimal ColonyBaseAscorbic AcidBinding (Molecular Function)BioinformaticsBladder CarcinomaBlocking AntibodiesAntibodiesCardiacCancer ImmunotherapyApoptosisCd27 AntigensCd34 MoleculeCd80 GeneCd8b1 GeneCd8 MoleculeBone Marrow Transplantation
Grant awards (12)
Safe and effective anti CD154 antibodies for therapeutic intervention$998,002
R44 · FY2013 · AI · contact PI
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity$300,000
R43 · FY2012 · AI · contact PI
EFFECT ANTIOXIDANT VITAMINS ON CARDIAC FUNCTION IN PATIENTS W/ AL AMYLOIDOSIS$6,251
M01 · FY2007 · RR · contact PI
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO THE TREATMENT OF AIDS$134,807
P51 · FY2006 · RR · contact PI
EVALUATION OF AN ANTI-GITR ANTIBODY IN MACAQUES WITH CHRONIC SIV INFECTION$134,807
P51 · FY2006 · RR · contact PI
EFFECT ANTIOXIDANT VITAMINS ON CARDIAC FUNCTION IN PATIENTS W/ AL AMYLOIDOSIS$3,860
M01 · FY2006 · RR · contact PI
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO THE TREATMENT OF AIDS$168,102
P51 · FY2005 · RR
XENOGENEIC THYMIC TRANSPLANTATION AS ADJUNCT TO THERAPY$204,218
P51 · FY2004 · RR
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO THE TREATMENT OF AIDS$245,841
P51 · FY2003 · RR
Immune Reconstitution by Thymic Organiod in Murine BMT$181,532
R43 · FY2003 · AI
RHESUS HEMATOPOIETIC CHIMERAS &ADOPTIVE T CELL TRANSFER$260,100
R21 · FY2000 · AI
RETROVIRAL INFECTION OF THE THYMUS IN AIDS PATHOGENESIS$117,998
R29 · FY2000 · AI